Safety of Arthritis Drugs, Day 2, Part 4
The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their…
Safety of Arthritis Drugs, Day 2, Part 1
2005-02-18T05:39:33-05:00https://images.c-span.org/defaults/capitol.jpgPhysicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial testing of the class of drugs, the review process at the FDA, and the medical issues in question. They also responded to questions from members of the committee.A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration… read more
Safety of Arthritis Drugs, Day 2, Part 1 Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial testing of the class of drugs, the review process at the FDA, and the medical issues in question. They also responded to questions from members of the committee.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close
People in this video
- Steven Abramson Chair New York University Medical School->Rheumatology
- Joan Bathon Professor Johns Hopkins University School of Medicine
- Dennis Boulware Professor University of Alabama, Birmingham->Medicine
- Byron Cryer M.D. Professor University of Texas at Dallas->Southwestern Medical School
- Ralph D'Agostino Professor Boston University->Public Health and Statistics
- Ruth Day Senior Fellow Duke University->Aging Center
- John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
- Thomas Fleming Chairman University of Washington->Biostatistics
- Lawrence Friedman Official National Institutes of Health
- Allan Gibofsky Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
- David Graham Medical Officer U.S. Food and Drug Administration->Pharmaceutical Science
- Charles Hennekens Professor University of Miami->School of Medicine
- Louis Morris President Louis A. Morris and Associates
- Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
- Robert O'Neil Director U.S. Food and Drug Administration->Biostatistics
- Richard Platt Professor Harvard University->Medical School
- Steven Schafer Professor Stanford University->School of Medicine
- Annette Stemhagen Official Covance Periapproval Services
- Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
- Kimberly Topper Executive Secretary U.S. Food and Drug Administration->Center for Drug Evaluation and Research
- Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
Hosting Organization
- U.S. Food and Drug AdministrationU.S. Food and Drug Administration
More Videos From
Safety of Arthritis Drugs, Day 2,
More Videos
Purchase a DVD or Download
Safety of Arthritis Drugs, Day 2, Part 1
-
DVD
- Price:
- $29.95
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
-
Safety of Arthritis Drugs, Day 3. Part 4
This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees.…
-
Safety of Arthritis Drugs, Day 3, Part 3
At a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis…
-
Safety of Arthritis Drugs, Day 1, Part 4
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drugs Celebrex, Bextra, Parecoxib,…
User Created Clips from This Video
-
- 3 minutes
- 2 views